Last checked at 9 Mar 2015 09:06
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Transense Share News (TRT)
TRT Share
Price
TRT Share
News
TRT Share
Chat
TRT Share
Trades
TRT
Live RNS
TRT Share
Charts
TRT Level 2
Console
TRT Live
Share Price
TRT Broker
Ratings
TRT Directors
Deals
TRT Financial
Diary
TRT
Fundamentals
TRT Short
Positions
TRT
Media
Transense Information
Share Price Information for Transense (TRT)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
116.50
Bid:
115.00
Ask:
118.00
Change:
0.00 (0.00%)
Spread:
3.00 (2.609%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
116.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Small caps round-up: Transense Tech, Hightex, Verona Pharma
Tue, 28th Aug 2012 14:43
Transense Technologies, which provides sensor systems for the transportation and industrial markets, has reported that its trading division, Translogik, has received an initial order for its iTrack Tyre Temperature and Pressure Monitoring Systems for mining and off-the-road vehicles from its Indonesian distributor, AutoRFID Solutions. The system will be installed as part of a pilot scheme on three of the 168 vehicles at the ADARO mine in Indonesia, one of AutoRFID's clients. Graham Storey, Chief Executive Officer of Transense, said it is "very encouraging that our success in South Africa has triggered this order in what is a new territory for us".Hightex Group, a systems engineering company, has been selected, along with its Brazilian construction partner SEPA, to engineer and install the membrane structure of the roof of the Beira-Rio Stadium in Porto Alegre, a 2014 FIFA World Cup venue. The deal, which has a value in the region of €10m, marks the firm's second contract win in Brazil. The stadium is the fifth largest in Brazil, and will accommodate around 50,000 spectators. Work will begin immediately and is due to be completed in 2013. Verona Pharma, a drug discovery company, has been granted a new patent for its lead drug candidate, RPL554, in the US. The product is being developed for the treatment of patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The company is currently carrying out clinical trials of the drug to further characterise its bronchodilator and anti-inflammatory effects. NR
More News
9 Mar 2015 07:58
28 Oct 2014 12:50
28 Oct 2014 11:18
13 Jun 2014 13:25
Transense Technologies warns on full-year revenue
Transense Technologies on Friday warned that its turnover for the year ending June 30th will be lower than previously estimated, generating an overall loss. The firm, which develops non-contact battery-less sensors, explained that the length of its sales cycle has proven greater than expected, but
Read more13 Jun 2014 11:29
UK MIDDAY BRIEFING: Property Companies Get Indigestion
LONDON (Alliance News) - UK residential and commercial property companies are among the biggest fallers in a declining market Friday, after Bank of England Governor Mark Carney said the interest rates in the UK could rise sooner than investors expect and Chancellor of the Exchequer George Osbo
Read more13 Jun 2014 10:35
UK WINNERS & LOSERS: Oil And Gas Stocks Rise Alongside Iraq Tensions
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday.
-------
FTSE 100 - WINNERS
-------
Tullow Oil, up 1.9%, Royal Dutch Shell, up 0.5% BG Gr
13 Jun 2014 07:34
UK MORNING BRIEFING: Iraq Worries Weigh; Petra Finds Blue Diamond
LONDON (Alliance News) - The deteriorating situation in Iraq has depressed shares early Friday, as the UK market also contemplates a sooner-than-expected rise in interest rates by the Bank of England.
SSE, Tullow Oil and BG Group le
13 Jun 2014 06:53
Transense Technologies Warns It Now Expects To Make Ebitda Loss
LONDON (Alliance News) - Transense Technologies PLC Friday said it now expects to post a loss before interest, tax, depreciation and amortisation for its current financial year, albeit a narrower loss than last year, after it experienced delays in getting some new orders. In a statement, th
Read more25 Feb 2014 14:08
DIRECTOR DEALINGS: Transense Non-Executive Deputy Chairman Transfers Shares
LONDON (Alliance News) - Transense Technologies PLC Tuesday said non-executive deputy Chairman David Kleeman transferred a total of 794,444 shares to his children and grandchildren at no cost Monday, therefore his total shareholding remains unchanged at 4.5 million shares, equating to 1.6% of the
Read more4 Feb 2014 14:17
Transense Technologies swings to maiden EBITDA profit in H1
The share price of AIM-listed Transense Technologies surged on Tuesday after the company revealed that it swung to a maiden underlying operating profit in the first half as revenues more than doubled. Chairman David Ford labelled it as a "significant watershed moment" for the firm. The Oxfordshire
Read more